Mesotherapy for Melasma - An Updated Review.

Kashikar, Yash; Madke, Bhushan; Singh, Adarshlata; Meghe, Soham; Rusia, Kaveri

Kashikar, Yash; Madke, Bhushan; Singh, Adarshlata; Meghe, Soham; Rusia, Kaveri.

Afiliación

Kashikar Y; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
Madke B; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
Singh A; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
Meghe S; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.
Rusia K; Department of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India.

J Pharm Bioallied Sci ; 16(Suppl 2): S1055-S1056, 2024 Apr.

Article en En | MEDLINE | ID: mdl-38882767

ABSTRACT

ABSTRACT

Mesotherapy is a popular novel therapeutic modality that delivers intradermal or subcutaneous microinjections of pharmaceutical compounds. Although this novel treatment method is used commonly in aesthetic dermatology, there is little information about the details of injections, efficacy, and side effects of mesotherapy in melasma. In this review, we evaluated the efficacy of various types of anti-pigmentation agents used with mesotherapy in the management of melasma.

Palabras clave

Anti-melanin agents; melasma; tranexamic acid

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pharm Bioallied Sci Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google